Clinical trial
An Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study
NCT03560167 is registered in ClinicalTrials.gov with Ancora Heart, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation - The CorCinch-PMVI Study
- Lead sponsor
- Ancora Heart, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 24, 2018
- Completion date
- January 28, 2024
- Enrollment
- 5 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.